The prognostic value and effects of gene polymorphism of Dox-metabolizing enzymes (including ABCC and CYP1B1 polymorphism) on BC survival were not reported, although large BC databases have been made publicly available for some time. This evidence concerns the gene ABCC1 and breast cancer.